Diabetic Peripheral Neuropathy News and Research

RSS
According to the National Institute of Diabetes & Digestive & Kidney Diseases, approximately half of those with diabetes have some form of nerve damage, or neuropathy, but not all will develop symptoms. While nerve problems can occur at any time, the highest rates are among those who have had diabetes for at least 25 years. People who have had problems controlling their blood sugar levels, have high blood pressure, are overweight, have high levels of blood fat, or are over the age of 40, may also have a greater risk of developing diabetic peripheral neuropathy. Symptoms can include numbness, tingling or pain and weakness in the toes, feet, legs, hands, arms and fingers. These symptoms are often worse at night.
NeuroMetrix to introduce NC-stat DPNCheck device for diabetic peripheral neuropathy

NeuroMetrix to introduce NC-stat DPNCheck device for diabetic peripheral neuropathy

Simple eye scan can detect early signs of diabetes-related nerve damage

Simple eye scan can detect early signs of diabetes-related nerve damage

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

CDA launches new awareness campaign about risk of developing type 2 diabetes

CDA launches new awareness campaign about risk of developing type 2 diabetes

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

XenoPort third quarter net loss decreases to $19.9 million

XenoPort third quarter net loss decreases to $19.9 million

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Researchers develop KU-32 drug to prevent diabetic peripheral neuropathy

Researchers suggest Hsp70 can reverse Diabetic peripheral neuropathy

Researchers suggest Hsp70 can reverse Diabetic peripheral neuropathy

NeuroMetrix second-quarter total revenues decrease to $3.9 million

NeuroMetrix second-quarter total revenues decrease to $3.9 million

Pfizer suspends chronic low back pain, diabetic peripheral neuropathy studies in tanezumab clinical program

Pfizer suspends chronic low back pain, diabetic peripheral neuropathy studies in tanezumab clinical program

Forest Laboratories, Gedeon Richter report positive results from radiprodil Phase II study for DPNP pain

Forest Laboratories, Gedeon Richter report positive results from radiprodil Phase II study for DPNP pain

Pfizer announces suspension of osteoarthritis clinical program for tanezumab

Pfizer announces suspension of osteoarthritis clinical program for tanezumab

Combination therapy improves patients with depression symptoms: Study

Combination therapy improves patients with depression symptoms: Study

The Neuropathy Association joins with the Empire State Building to recognize National Neuropathy Week

The Neuropathy Association joins with the Empire State Building to recognize National Neuropathy Week

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

Study evaluates cost benefits of new interventions for treating, preventing PDN and PHN

Folate-enriched prescription medical food lowers medical costs of patients with peripheral neuropathy

Folate-enriched prescription medical food lowers medical costs of patients with peripheral neuropathy

HealthCore study shows Metanx tablets reduces health plan costs

HealthCore study shows Metanx tablets reduces health plan costs

Biochemics signs research collaboration agreement with Unilever

Biochemics signs research collaboration agreement with Unilever